The Dr. Holhoș network has inaugurated the largest private ophthalmology hospital in Transylvania, following an investment of approximately €6 million.
Romanian patients wait, on average, 460 days to access innovative medicines, even after these therapies have been approved for reimbursement by the National Agency for Medicines and Medical Devices (ANMDM).
7X Partners, a private equity investment company, has acquired a 40% stake in Leventer Medical Group, a centre for dermato-oncology based in Bucharest.
The agreement signifies a joint commitment to enhance healthcare infrastructure in Romania.
ING Bank Romania has financed Medisprof Group, which owns the largest private oncology hospital in western Romania, to expand in the region of Moldova.
The current conflict in Iran may only have a marginal impact on the global economy, according to an opinion by stock exchange broker Investimental.
Romanian energy company Simtel Team has appointed Petre Stoian as CEO to consolidate its management structure as the group expands its operations.
The Romanian government has adopted an emergency ordinance for administrative reform that officially recognises what specialists have long signalled: public administration is oversized, fragmented and financially unsustainable, according to an opinion by PwC Romania experts Dinu Bumbăcea and Cristian Cortez.
Romania continues to lag significantly behind the European average regarding the modernisation of its rail infrastructure.
Romania's Ministry of Finance has announced a new spring edition of its Tezaur government bond programme, offering citizens attractive investment opportunities with annual interest rates reaching 7%.